Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 27, 2012
[ 06:33 AM ] - United States, Market Wire
[ 05:41 AM ] - United States, WOPRAI
[ 05:40 AM ] - United States, WOPRAI
[ 05:40 AM ] - United States, WOPRAI
[ 05:40 AM ] - United States, WOPRAI
[ 05:40 AM ] - United States, WOPRAI
[ 05:00 AM ] - United States, Market Wire
[ 04:23 AM ] - United States, WOPRAI
[ 04:22 AM ] - United States, WOPRAI
[ 04:22 AM ] - United States, WOPRAI
[ 04:21 AM ] - United States, WOPRAI
[ 04:21 AM ] - United States, WOPRAI
[ 04:21 AM ] - United States, WOPRAI
[ 04:21 AM ] - United States, WOPRAI
[ 04:20 AM ] - United States, WOPRAI
[ 04:20 AM ] - United States, WOPRAI
[ 03:03 AM ] - United States, WOPRAI
[ 03:02 AM ] - United States, WOPRAI
[ 03:02 AM ] - United States, WOPRAI
[ 03:02 AM ] - United States, WOPRAI
[ 03:02 AM ] - United States, WOPRAI
[ 03:01 AM ] - United States, WOPRAI
[ 03:01 AM ] - United States, WOPRAI
[ 03:01 AM ] - United States, WOPRAI
[ 03:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Christopher Raymond Upgraded (AMGN) to Buy and Increased Target to $95 on, Jul 27th, 2012
Christopher Raymond of Piper Sandler, Upgraded "Amgen Inc." (AMGN) to Buy and Increased Target from $77 to $95 on, Jul 27th, 2012.
Christopher has made no other calls on AMGN in the last 4 months.
There is 1 other peer that has a rating on AMGN. Out of the 1 peers that are also analyzing AMGN, all agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Salveen Richter of "Goldman Sachs" Maintained at Hold with Increased Target to $67 on, Wednesday, April 25th, 2012
